Dio Tree Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2M

  • Investors
  • 4

Dio Tree General Information

Description

Developer of small-molecule enzyme inhibitors designed to treat high-grade serous ovarian cancer and other DIO3-expressing tumors. The company's platform focuses on designing and patenting drug-like small molecules that selectively inhibit the iodothyronine deiodinase type 3 enzyme to reduce thyroid-hormone inactivation and suppress tumor-supporting signaling, with preclinical evaluation in cancer cell and mouse xenograft models and supporting toxicology work, enabling ovarian cancer and other aggressive solid-tumor treatment settings to add a targeted option for patients who have limited benefit from standard chemotherapy, surgery, or mutation-restricted therapies.

Contact Information

Formerly Known As
DioTarget
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Wadi el-Haj Street13
  • Nazareth 1711102
  • Israel
+972
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Wadi el-Haj Street13
  • Nazareth 1711102
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dio Tree Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 01-Dec-2022 $2M Completed Generating Revenue
To view Dio Tree’s complete valuation and funding history, request access »

Dio Tree Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dio Tree Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arieli Group Venture Capital Minority
Hadasit Venture Capital Minority
Innovation Authority Government Minority
NGT HealthCare II Venture Capital Minority
To view Dio Tree’s complete investors history, request access »

Dio Tree FAQs

  • When was Dio Tree founded?

    Dio Tree was founded in 2022.

  • Where is Dio Tree headquartered?

    Dio Tree is headquartered in Nazareth, Israel.

  • What is the size of Dio Tree?

    Dio Tree has 4 total employees.

  • What industry is Dio Tree in?

    Dio Tree’s primary industry is Drug Discovery.

  • Is Dio Tree a private or public company?

    Dio Tree is a Private company.

  • What is Dio Tree’s current revenue?

    The current revenue for Dio Tree is .

  • How much funding has Dio Tree raised over time?

    Dio Tree has raised $2M.

  • Who are Dio Tree’s investors?

    Arieli Group, Hadasit, Innovation Authority, and NGT HealthCare II have invested in Dio Tree.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process